Trial intelligence / Profile preview

Sodium tetradecyl sulfate 1% with ceftazidime and metronidazole for perianal fistula

IRCT2013051913385N1Phase 3Completed

Sponsor
Ahvaz Jundishapur University of Medical Sciences
Start
Oct 2011
Modality
Reversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules, Small Molecules, Recombinant Proteins and Enzymes
Countries
1
01

Overview

Phase 3, single-arm trial of sodium tetradecyl sulfate, ceftazidime and metronidazole in anal fistula, sponsored by Ahvaz Jundishapur University of Medical Sciences. Started Oct 2011; status: completed.

02

Drugs

sodium tetradecyl sulfateceftazidimemetronidazole
03

Conditions

anal fistula

Beyond the preview

Go deeper on IRCT2013051913385N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT2013051913385N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call